Atomoxetine impurity D CRS, with the CAS number 873310-29-3, is a chemical substance that serves as a reference standard in analytical chemistry, particularly in the context of pharmaceutical development and quality control. This compound is an impurity associated with atomoxetine, a selective norepinephrine reuptake inhibitor used primarily in the treatment of attention deficit hyperactivity disorder (ADHD). The characteristics of this impurity include its molecular structure, which may differ slightly from the parent compound, leading to variations in its physical and chemical properties. Typically, impurities like Atomoxetine impurity D are characterized by their solubility, stability, and reactivity, which can influence the overall efficacy and safety profile of the drug. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities in pharmaceutical formulations. Understanding the characteristics of impurities is crucial for ensuring the quality and compliance of pharmaceutical products with regulatory standards.

Atomoxetine impurity D CRS

873310-29-3: Atomoxetine impurity D CRS, with the CAS number 873310-29-3, is a chemical substance that serves as a reference standard in analytical chemistry, particularly in the context of pharmaceutical development and quality control. This compound is an impurity associated with atomoxetine, a selective norepinephrine reuptake inhibitor used primarily in the treatment of attention deficit hyperactivity disorder (ADHD). The characteristics of this impurity include its molecular structure, which may differ slightly from the parent compound, leading to variations in its physical and chemical properties. Typically, impurities like Atomoxetine impurity D are characterized by their solubility, stability, and reactivity, which can influence the overall efficacy and safety profile of the drug. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities in pharmaceutical formulations. Understanding the characteristics of impurities is crucial for ensuring the quality and compliance of pharmaceutical products with regulatory standards.

CAS 873310-29-3

Atomoxetine impurity D CRS

Atomoxetine USP Related Compound B

Ref: ST-EA-CP-A30019